Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.

Slides:



Advertisements
Similar presentations
MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.
Advertisements

Assisted Circulation MEDICAL MEDICAL  Drugs  EECP MECHANICAL  IABP ( Introaortic balloon pump)  VAD (Ventricular assist device)
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
Innovative Minimally Invasive Circulatory Assist Device.
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings From the National Heart, Lung, and Blood.
PCI VS CABG JOURNAL REVIEW
Seung-Jung Park, MD, PhD On behalf of the PRECOMBAT Investigators Professor of Medicine, University of Ulsan College of Medicine, Heart Institute, Asan.
ST-Elevation Myocardial Infarction & Cardiogenic Shock - What Should We Do? Advanced Angioplasty 2008 Dan Blackman Leeds General Infirmary.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Ischemic heart disease. Indications and methods of surgical treatment. Surgery department №2.
New guidelines for CABG
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Percutaneous Mechanical Circulatory Support Devices
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
Ihab Alomari, MD, FACC Assistant professor – Interventional Cardiology University of California, Irvine Division of Cardiology Cath Lab Essentials : LV.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.
Samuel Thomas Rayburn, III MD Cardiovascular Surgeon Jack Stephens Heart Institute April 25, 2015.
Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Survival of patients with diabetes and multivessel.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: A comparison of three-year survival after coronary.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
VASIL VELCHEV ST. ANNA HOSPITAL, SOFIA. Conflict of interest:
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Medical Therapy With Versus Without Revascularization.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Readmissions After Carotid Artery Revascularization.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Conflict of Interest Baxter Research Grant Medtronic Research Grant
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Echocardiography for Percutaneous Heart Pumps J.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Treatment of Protected and Unprotected.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.
IABP-SHOCK II Score Stratifies Patient Risk in CS after AMI
Contemporary Approaches to Acute Mechanical Circulatory Support
Improving Outcomes in Cardiogenic Shock
University of Chicago Medicine
Complex Coronary intervention
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Successful CTO PCI Associated with Lower Mortality Risk
Mechanical circulatory support
Catheter-Based Treatment of Coronary Artery Disease
The Use of Impella for CGS Patients Does It Save Lives?
Glenn N. Levine et al. JACC 2016;68:
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Giuseppe Biondi Zoccai, MD
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Peter K. Smith, MD  The Annals of Thoracic Surgery 
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Risk Stratification and Interventional Cardiology: Robert L
Long-term outcome of revascularization with composite T-grafts: Is bilateral mammary grafting better than single mammary and radial artery grafting? 
IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.
Glenn N. Levine et al. JACC 2011;58:e44-e122
Leslee J. Shaw et al. JIMG 2010;3:
Davide Capodanno et al. JCIN 2009;2:
Presentation transcript:

Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis / Johnson and Johnson Abbott

Patient E.T. 84 y.o. retired game warden 6 month history of progressive dyspnea (~15 feet), orthopnea, PND No angina Echo: dilated cardiomyopathy EF = 20% Moderate CRF Cr = 2.0 mg/dl Occluded left internal carotid artery

Percutaneous LVAD (TandemHeart TM ) Logistic Euroscore 36.8 %

Percutaneous LVAD insertion (TandemHeart TM ) 21 Fr. Left atrial inflow cannulae 15 or 17 Fr. Femoral arterial outflow catheter 4 – 4.5 L/min flow

AHA Heart Disease and Stroke Statistics – 2005 Update Prevalence of Congestive Heart Failure by Age (NHANES 1999 – 2004)

Hemodynamic Support for High-Risk PCI Pressors and intravenous inotropes IABP  Reduced afterload  Increased diastolic perfusion pressure  Increased forward flow - MODEST Percutaneous Left Ventricular Assist

TandemHeart Support for Elective PCI in High-Risk Ischemic DCM at UW (11/21 cases from ) Preoperative Characteristics Age (yrs)73 ± 14 Unprotected LMCA5/11 EF (%)24 ± 8 Logistic Euroscore (30 d mortality, %) 32 ± 19

TandemHeart Support for Elective PCI in High-Risk Ischemic DCM Procedural Outcome Procedural Time (min)170 ± 37 Time to Pump (min)45 ± 6 Preclose/Hemostasis in Lab11/11 Mean Flow (L/min)3.1 ± 0.2 Vessels Treated2.3 ±1.2 Stents Deployed3.8 ± 1.7

TandemHeart Support for Elective PCI in High-Risk Ischemic DCM Hospital Course 30 day Survival10/11 Vascular Complications (Transfusion) 1/11 Other Complications (Atrial Lead Dislodged) 1/11

TandemHeart Support for Elective PCI in High-Risk Ischemic DCM Mean Follow up 20 ± 11 Months Survival (%)73 (deaths at 3, 4, 4 months) EF (%)44 ± 7

TandemHeart Support for Elective PCI in High- Risk Ischemic DCM ( 7 Survivors with ≥ 12 month F/U)

Indications for pLVAD High-risk PCI Cardiogenic shock  AMI  Decompensated chronic heart failure Post-op CABG RV support  RV infarct  Post-op CABG  Bi-ventricular failure with LVAD

Impella Recover LP 2.5 System NOT FOR SALE IN THE UNITED STATES *Caution: Investigational Device, limited by Federal law to Investigational Use 12 Fr Distal 2.5 L/min flow

Who to Revascularize? Myocardial Viability Clinical– angina MRI PET Thallium Dobutamine Echo

Tarakji, K. G. et al. Circulation 2006;113: Propensity-matched patients undergoing PET viability testing (306/765) at the Cleveland Clinic

Tarakji, K. G. et al. Circulation 2006;113: Association between predicted 3-year mortality and the amount of compromised viable myocardium (ischemic and hibernating) determined by PET/FDG study according to performance of early intervention among propensity-matched patients

Copyright ©2001 American College of Cardiology Foundation. Restrictions may apply. Berger, P. B. et al. J Am Coll Cardiol 2001;38: How to revascularize? BARI Survival curves of patients with three-vessel disease and reduced ventricular function undergoing percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) in the Bypass Angioplasty Revascularization Investigation

Copyright ©2001 American College of Cardiology Foundation. Restrictions may apply. Morrison, D. A. et al. J Am Coll Cardiol 2001;38: AWESOME Kaplan-Meier survival plot of coronary artery bypass graft surgery (CABG) (circles) versus percutaneous coronary intervention (PCI) (squares)

Copyright ©2001 American College of Cardiology Foundation. Restrictions may apply. Morrison, D. A. et al. J Am Coll Cardiol 2001;38: AWESOME Kaplan-Meier plot of survival free of unstable angina (UA) or repeat revascularization for coronary artery bypass graft surgery (CABG) (circles) versus percutaneous coronary intervention (PCI) (squares)

DES in Higher Risk Settings

DES vs CABG Trials Syntax Cardia Freedom

Percutaneous Therapy for DCM PCI (with or without hemodynamic support) Percutaneous valve therapies Cellular therapies